Global Organic Pharmaceutical Excipients Market Size is valued at USD 10.2 Billion in 2024 and is predicted to reach USD 27.6 Billion by the year 2034 at an 10.7% CAGR during the forecast period for 2025-2034.
Organic pharmaceutical excipients are naturally used in supplements to active medicinal compounds in producing pharmaceutical products. They come from renewable resources, such as microbes, vegetation, or livestock, and are usually considered safe for medicinal applications. The market is expanding due to the increasing demand for organic and conventional products in pharmaceutical applications, as consumers are opting for items that are perceived as more environmentally friendly and safer. The demand for organic pharmaceutical excipients is also being driven by the increasing investment in research and development by both public and private entities. Pharmaceutical companies and academic institutions are collaborating to foster innovation, which leads to the creation of new excipients with superior functional properties. The competitive environment is enhanced and a consistent supply of cutting-edge organic excipients is guaranteed through this collaboration between industry and research, which in turn drives market expansion.
However, the pharmaceutical excipients industry is fraught with patent and trademark problems, especially as patenting innovative excipient technology can put smaller businesses and new competitors at a competitive disadvantage. Larger corporations limit access to these essential components when they get patents for novel excipients, is hindering smaller businesses' capacity to form and sell competitive goods. The market may become less competitive as a result, which might hinder the creation of novel formulations that could meet unmet medical requirements.
Competitive Landscape
Some of the Key Players in the Organic Pharmaceutical Excipients Market:
- Roquette Freres SA
- DuPont de Nemours Inc.
- Ashland Inc.
- BASF SE
- Kerry Group plc
- Evonik Industries AG
- Croda International plc
- The Lubrizol Corporation
- Innophos Holdings Inc.
- Wacker Chemie AG
Market Segmentation:
The organic pharmaceutical excipients market is segmented based on type, function, and end-user. Based on the type, the market is segmented into oleochemicals, carbohydrates, petrochemicals, protein, and others. Based on the function, the market is segmented into coating agents, colorant disintegrates, and other functions. Based on the application, the market is segmented into oral formulations, topical formulations, parenteral formulations, and other applications.
Based on the Function Drug, the Disintegrates Segment is Accounted as a Major Contributor to the Organic Pharmaceutical Excipients Market
Disintegrates are expected to hold a major global market share in 2021 in the organic pharmaceutical excipients market because of their capacity to preserve drugs' effectiveness while improving their protection. Since organic disintegrants have quicker disintegration circumstances and better patient compliance, their use is being fueled by a growing emphasis on ease of use and better therapeutic results. Expanding possibilities for organic excipients in intricate medication formulations are anticipated as a result of the ongoing advancements in disintegrant technologies.
Oral Formulations segment to witness growth at a rapid rate
The oral formulations segment is growing in the organic pharmaceutical excipients market due to patient acceptance and their simplicity of use. Because organic excipients have superior security profiles and higher absorption, there is an increasing need for them in oral formulations. The popularity of organic excipients is being further fueled by the invention of novel forms of ingestion, especially controlled-release formulations and fast-dissolving tablets, which make it easier to produce more patient-friendly and reliable treatments.
Regionally, the North American Organic Pharmaceutical Excipients market holds a significant revenue share
The North American organic pharmaceutical excipients market is predicted to register the highest market share in revenue shortly. The regional growth can be attributed to its substantial priority for inventiveness, sophisticated research infrastructure, and thriving pharmaceutical business. The development of organic excipients is encouraged by the legal framework in the area, where organizations such as the FDA promote safer and more sustainable pharmacological components. In addition, the Asia Pacific is expected to develope rapidly in the organic pharmaceutical excipients market because of the expanding manufacturing of the medications industry, the population that is expanding quickly, and greater awareness of medical concerns. Organic excipients are becoming more and more popular in the area due to increasing consumer preference for goods that are organic and natural, as well as a greater focus on safety and effectiveness.
Organic Pharmaceutical Excipients Market Report Scope :
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 10.2 Billion |
|
Revenue Forecast In 2034 |
USD 27.6 Billion |
|
Growth Rate CAGR |
CAGR of 10.7% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Function, Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Roquette Freres SA, DuPont de Nemours Inc., Ashland Inc, BASF SE, Kerry, Group plc, Evonik Industries AG, Croda International plc, The Lubrizol Corporation, Innophos Holdings Inc, Wacker Chemie AG |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
